Carregant...
Glutamatergic Modulators in Depression
Both preclinical and clinical studies have implicated glutamatergic system dysfunction in the pathophysiology of mood disorders such as bipolar depression and major depressive disorder (MDD). In particular, rapid reductions in depressive symptoms have been noted in response to subanesthetic doses of...
Guardat en:
| Publicat a: | Harv Rev Psychiatry |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6102095/ https://ncbi.nlm.nih.gov/pubmed/29465478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HRP.0000000000000183 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|